Trial Profile

Phase III clinical trial of S-7701 in patients with idiopathic pulmonary fibrosis

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 18 Jun 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Pirfenidone (Primary)
Indications Idiopathic pulmonary fibrosis
Focus Therapeutic Use
Sponsors Shionogi Pharma

Most Recent Events

05 Jun 2021 Results of post-hoc exploratory analysis assessing efficacy and safety of pirfenidone over 52 weeks published in the Chest
27 Jun 2020 New trial record
20 May 2020 Results of post-hoc analysis of japanese phase III clinical trial, presented at the 116th International Conference of the American Thoracic Society

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com